• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB Back to Search Results
Catalog Number 7D2648
Device Problem False Negative Result (1225)
Patient Problems HIV, Human Immunodeficiency Virus (2197); No Known Impact Or Consequence To Patient (2692); No Information (3190)
Event Date 07/04/2019
Event Type  malfunction  
Manufacturer Narrative
Testing was performed at abbott diagnostics (b)(4), inc.On retained kit lots: 102997, and 108538 with the following serum/plasma control samples: (b)(6).All test results were valid and performed as expected.The customer returned the patient sample collected on (b)(6) 2019.The sample was tested with x1 device from each kit lot.Both tests yielded valid, reactive p24 antigen results.Please note: the customer stated they stored the samples at a refrigerated temperature since collection.The sample arrived at abbott diagnostics (b)(4) on tested on (b)(6) 2019.According to the package insert under the section specimen storage: serum and plasma specimens may be stored at room temperature (15- 30°c) for up to two days before testing.If testing will not be performed within two days of sample collection, serum and plasma specimens should be stored at 2- 8°c if the test is to be run within 7 days of collection.If testing is delayed more than 7 days, the specimen should be frozen (-20°c or colder).The manufacturing batch records for lots: 102997 and 108538 were reviewed.This lot met the required release specifications.A review of the complaints reported as (b)(6) related to lot numbers 102997 and 108538 showed that the complaint rate is (b)(4)., respectively.The evidence available does not indicate that the product is performing outside label claims.Abbott diagnostics (b)(4), inc.Was unable to determine the exact root cause of the reported issue.
 
Event Description
A customer reported a (b)(6) result on a serum sample (collection date: (b)(6) 2019) with the alere determine hiv-1/2 ag/ab combo test (kit lot # 102997) on a male patient.Confirmatory testing from a serum sample (collection date: (b)(6) 2019) produced (b)(6) results with the abbott architect; (b)(6) results with the biorad geenius; (b)(6) results with an hiv-1 rna qualitative assay (not otherwise specified).Repeat testing on (b)(6) 2019 of the serum samples, collection dates: (b)(6) 2019 and (b)(6) 2019 were negative with the alere determine hiv-1/2 ag/ab combo test (kit lot # 102997).Additional testing (serum sample, collection date: (b)(6) 2019) was negative with the alere determine hiv-1/2 ag/ab combo test on (b)(6) 2019 with kit lot # 108538.Testing of the serum sample, collection date: (b)(6) 2019, produced (b)(6) results with the abbott architect and (b)(6) results with the biorad geenius when tested.Note: package insert specimen storage states: serum and plasma specimens may be stored at room temperature (15- 30°c) for up to two days before testing.If testing will not be performed within two days of sample collection, serum and plasma specimens should be stored at 2- 8°c if the test is to be run within 7 days of collection.If testing is delayed more than 7 days, the specimen should be frozen (-20°c or colder).Mix specimen well by gentle inversion of the tube immediately before testing.Treatment and patient outcome were not reported.There is insufficient information to determine if a malfunction occurred.Attempts to gain additional information were not successful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV-1/2 AG/AB COMBO
Type of Device
IVD FOR HIV 1/2 AG/AB
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer (Section G)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
erin rowley
10 southgate road
scarborough, ME 04074
2077305858
MDR Report Key8887707
MDR Text Key219159755
Report Number1221359-2019-00057
Device Sequence Number1
Product Code MZF
UDI-Device Identifier10811877010293
UDI-Public011081187701029310102997
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP120037-0
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Administrator/Supervisor
Type of Report Initial
Report Date 08/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/22/2020
Device Catalogue Number7D2648
Device Lot Number102997
Was Device Available for Evaluation? No
Date Manufacturer Received07/15/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/02/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age33 YR
-
-